Improving HIV clinical trials in Liberia
Official title: Advancing Clinical Trials on HIV (ACTonHIV) in Liberia
Funded at University of Liberia College of Health Sciences · NIH-11179015 · Data updated 2026-11-12
This study is working to improve how we handle HIV in Liberia by helping people learn more about the virus, encouraging more testing, and building a strong team to provide better care, all while making sure the solutions fit the needs of the community.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Liberia College of Health Sciences NIH-funded |
| Lab location | 1 site (Monrovia, Liberia) |
| Project start | May 5, 2025 |
| Project end | February 28, 2027 |
| Funding year | 2025 |
| Award (this year) | $29,636 |
| NIH project number | 1D71TW013085-01 |
| Project ID | NIH-11179015 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals living with HIV in Liberia, as well as those at risk of HIV infection.
✕Less likely to help
Patients who are not residing in Liberia or those who do not have access to HIV-related healthcare services may not benefit from this research.
What this research studies
This research aims to enhance the capacity for conducting clinical trials on HIV in Liberia, addressing significant public health challenges related to HIV/AIDS. It focuses on improving knowledge about HIV, increasing testing rates, and developing the necessary workforce and infrastructure to support high-quality HIV service delivery. The project will also work on implementing rigorous scientific methods to improve the country's HIV response, ensuring that interventions are tailored to the local context. By collaborating with local institutions, the research seeks to build sustainable capabilities for future clinical trials.
Why it matters
Potential benefit: If successful, this research could lead to improved HIV treatment and prevention strategies that are specifically designed for the Liberian population.
How similar studies have gone: While there have been advancements in HIV clinical research globally, this specific approach in Liberia is novel and aims to address unique local challenges.
Where this research is happening
-
University of Liberia College of Health Sciences
Monrovia, Liberia Active
Researchers
- Principal investigator: Wachekwa, Ian — University of Liberia College of Health Sciences
- Study coordinator: Wachekwa, Ian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.